VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for Castle Biosciences Inc Common Stock (CSTL)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Castle Biosciences Inc Common Stock
Symbol: CSTL
Shares outstanding: 28,020,413 shares
Disclosed Ownership: 1,832,535 shares
Ownership: 6.54%
Form type: SCHEDULE 13G/A
Filing time: 30 Jan 2025, 21:33:28 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	6.54%	1,832,535	0	28,884	Ashley Grim	Head of Global Fund Administration